Tenderwize
Back to tender search

Open-house Lenograstim rebate agreement

Techniker Krankenkasse·Hamburg, Germany·Deadline Dec 30, 2027 · 498 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-30 - Lenograstim

46/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

46 / 100

Complexity

58 / 100

Risk factors

Portal submission is not allowed; contracts must be sent by email with qualified electronic signature or by post, which...

Participation is restricted to pharmaceutical undertakings for the relevant product, with seat and authorisation requir...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Dec 2027
  • Conclusion of rebate agreements for the active substance Lenograstim under an open-house procedure.
  • Supply of pharmaceutical products (CPV 33600000).
Show full summary

Open-house supply arrangement for Lenograstim pharmaceutical products in Germany, led by Techniker Krankenkasse with HEK and hkk participating. The notice states no exclusivity, no individual negotiations, and uniform terms for all eligible pharmaceutical companies. Contracting can occur throughout the term, but the agreement ends no later than 31.12.2027. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post, with portal communication used for questions. No contract value is stated.

Risks

Portal submission is not allowed; contracts must be sent by email with qualified electronic signature or by post, which...

Participation is restricted to pharmaceutical undertakings for the relevant product, with seat and authorisation requir...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Applicant must be a pharmaceutical undertaking within the meaning of Section 4(18) AMG for the offered medicinal products.
  • Applicant must have its seat in the AMG territory, another EU Member State, or another EEA state.
  • Applicant must hold a valid marketing authorisation for the relevant medicinal product(s), or otherwise be entitled to place them on the market in its own name.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open-house Lenograstim rebate agreement

Open-house contract for pharmaceutical rebate agreements under Section 130c(1) SGB V for the active substance Lenograstim. Scope is nationwide in Germany. The lot information comes from structured data and the notice text.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Dec 2025 - Dec 2027

Category

Pharmaceutical products

Deadline

Deadline Dec 30, 2027

Procurement Details

Publication date
23 Apr 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
282722-2026

Documents (1)

Similar tenders